Skip to main content
Top
Published in: Critical Care 1/2019

Open Access 01-12-2019 | Letter

Endocan is a reliable biomarker during continuous renal replacement therapy

Authors: Maxence Hureau, Alexandre Gaudet, Nathalie De Freitas Caires, Erika Parmentier, Julien Poissy, Thibault Duburcq, Philippe Lassalle, Daniel Mathieu

Published in: Critical Care | Issue 1/2019

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Honore PM, De Bels D, Attou R, Redant S, Gallerani A, Kashani K. Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker? Crit Care Lond Engl. 2019;23(1):184.CrossRef Honore PM, De Bels D, Attou R, Redant S, Gallerani A, Kashani K. Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker? Crit Care Lond Engl. 2019;23(1):184.CrossRef
2.
go back to reference Sarrazin S, Lyon M, Deakin JA, Guerrini M, Lassalle P, Delehedde M, et al. Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan. Glycobiology. 2010;20(11):1380–8.CrossRef Sarrazin S, Lyon M, Deakin JA, Guerrini M, Lassalle P, Delehedde M, et al. Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan. Glycobiology. 2010;20(11):1380–8.CrossRef
3.
go back to reference Clark WR, Gao D, Lorenzin A, Ronco C. Membranes and sorbents. Contrib Nephrol. 2018;194:70–9.CrossRef Clark WR, Gao D, Lorenzin A, Ronco C. Membranes and sorbents. Contrib Nephrol. 2018;194:70–9.CrossRef
4.
go back to reference De Freitas Caires N, Legendre B, Parmentier E, Scherpereel A, Tsicopoulos A, Mathieu D, et al. Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis. J Pharm Biomed Anal. 2013;78-79:45–51.CrossRef De Freitas Caires N, Legendre B, Parmentier E, Scherpereel A, Tsicopoulos A, Mathieu D, et al. Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis. J Pharm Biomed Anal. 2013;78-79:45–51.CrossRef
Metadata
Title
Endocan is a reliable biomarker during continuous renal replacement therapy
Authors
Maxence Hureau
Alexandre Gaudet
Nathalie De Freitas Caires
Erika Parmentier
Julien Poissy
Thibault Duburcq
Philippe Lassalle
Daniel Mathieu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2019
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-019-2585-4

Other articles of this Issue 1/2019

Critical Care 1/2019 Go to the issue